Nav: Home

Unnecessary antibiotic use in asthma exacerbations may increase hospital stay, costs

May 22, 2018

"Clinical guidelines, including the Global Initiative for Asthma, state that there is no role for antibiotics in asthma exacerbations unless there is strong evidence of lung infection," said lead study author Mihaela S. Stefan, MD, PhD, a research scientist at the Institute for Healthcare Delivery and Population Science and associate professor at the University of Massachusetts Medical School in Springfield.

Dr. Stefan noted that a prior study conducted by her research group found that 60 percent of patients received antibiotics without an indication of lung infection. "Nevertheless, few studies have assessed whether antibiotics could be beneficial in these patients," she added.

In the largest observational comparative effectiveness study to date, the researchers analyzed the medical records of patients hospitalized for asthma over a two-year period at 554 U.S. hospitals. They excluded patients with any potential reason for receiving antibiotics, including being diagnosed with a sinus infection, pneumonia, bronchitis, emphysema, sepsis or any other condition that should be treated with antibiotics.

Of the remaining 22,043 patients, 46.1 percent were treated with antibiotics within their first two hospital days. The researchers conducted several types of analyses. Using propensity-matched analysis, which they characterized as the most "robust," they found that those receiving antibiotics had:
  • longer hospital stays, 4.64 vs 3.4 days;
  • higher hospitalization costs, $6,427 vs. $5,387; and
  • a 55 percent higher risk of antibiotic-related diarrhea.

There was no difference in treatment failure between those who received antibiotics and those who did not. Treatment failure was defined as the initiation of invasive or noninvasive mechanical ventilation, transfer to the intensive care unit after hospital day two, and in-hospital mortality or readmission for asthma exacerbation within 30 days of discharge.

"Our results strengthen the evidence that antibiotics should not be prescribed routinely in adult patients hospitalized with asthma," Dr. Stefan said, adding that all patients in the study had received systemic steroids and bronchodilators, the standard of care for patients experiencing an asthma exacerbation. "All hospitals should assess their practice in caring for patients hospitalized with asthma and increase their antibiotic stewardship."

She added that her research group is planning a qualitative study to understand why physicians use antibiotics in asthma.
This abstract has been revised since the original abstract was submitted.

Abstract 16204

High Antibiotics Prescribing in Patients Hospitalized with Asthma Exacerbation - but Are Antibiotics Associated with Better Outcomes?

Authors: M. S. Stefan1, P. K. Lindenauer2, M. Shieh1, P. Pekow1; 1Hospital Medicine, Baystate Med Ctr, Springfield, MA, United States, 2Center for Quality of Care Research, Baystate Med Ctr, Springfield, MA, United States.

Importance: More than half of patients hospitalized for asthma receive antibiotics in the absence of a clear indication.

Objective: To compare the outcomes of patients hospitalized with asthma exacerbation and treated with antibiotic therapy with those not treated with antibiotics.

Design: Retrospective cohort study from January 1, 2015 through December 31, 2016

Setting: 554 acute care US hospitals

Participants: Patients 18 years or older, hospitalized with asthma exacerbation, and treated with systemic corticosteroids.

Exposure: Antibiotic treatment defined as an antibiotic initiated during the first two days of hospitalization and prescribed for a minimum of 2 days.

Main outcome and measures: length of stay. Other measures: 1) treatment failure: defined as the initiation of mechanical ventilation, or transfer to ICU after hospital day 2, or in-hospital mortality, or readmission for asthma within 30 days of discharge; 2) hospital costs; and 3) antibiotic-related diarrhea.

Results: Of the 22,043 patients 46.1% received antibiotics. Treated patients were older (mean age: 50.5 vs 46.6 years), more likely to be white (49.6% vs 41.5%) and smokers (7.6% vs. 5.5%), and had a higher number of comorbidities than those not treated. Compared with patients not treated with antibiotics, those treated with antibiotics had longer hospital stays (mean: 4.4 vs 3.4 days, p<0.0001), but similar treatment failure rate (5.56% vs. 5.64%). In propensity matched analysis, receipt of antibiotics remained associated with longer stay in the hospital (RR: 1.27; 95% CI, 1.25-1.29), higher cost of hospitalization (mean cost $6427 vs $5387), and increased risk of antibiotic-related diarrhea (OR: 1.55; 95% CI, 1.16-2.08), but not with an increased risk of treatment failure (OR: 1.02; 95% CI, 0.88-1.17). Multivariable adjustment and hierarchical modeling to account for possible confounders and the hospital effect, as well as several sensitivity analyses yielded similar results.

Conclusions and relevance: In conclusion, antibiotic therapy was not associated with reduce treatment failure however was associated with increased length of stay, hospital cost and antibiotic-related diarrhea. Our results strengthen the evidence that antibiotics should not be prescribed routinely in adults patients hospitalized with asthma.

American Thoracic Society

Related Asthma Articles:

Insomnia prevalent in patients with asthma
A team of researchers from the University of Pittsburgh has found that insomnia is highly prevalent in adults with asthma and is also associated with worse asthma control, depression and anxiety symptoms and other quality of life and health issues.
Test used to diagnose asthma may not be accurate
A new study urges caution in the use of the mannitol challenge test for asthma in non-clinical settings.
Turning off asthma attacks
Working with human immune cells in the laboratory, Johns Hopkins researchers report they have identified a critical cellular 'off' switch for the inflammatory immune response that contributes to lung-constricting asthma attacks.
Access to asthma meds, plus flu vaccines, keep kids with asthma healthy
Kids need flu shots to prevent asthma flares, and medications available in school to keep 86 percent in class, according to two studies being presented at the American College of Allergy, Asthma and Immunology Annual Scientific Meeting.
Discovery could lead to better asthma treatment
Scientists have made a discovery that could lead to improved treatment for asthma sufferers.
Do asthma and COPD truly exist?
Defining a patient's symptoms using the historical diagnostic labels of asthma and chronic obstructive pulmonary disease (COPD) is an outdated approach to understanding an individual's condition, according to experts writing in the European Respiratory Journal today.
Asthma in many adolescents is not an allergic disease
New research indicates that asthma in many adolescents is not likely to involve inflammation of the airways and therefore should not be considered an allergic disease.
First classification of severe asthma
Severe asthma can have a devastating effect on sufferers, affecting their ability to work or go to school and to lead normal lives.
Exploring 'clinical conundrum' of asthma-COPD overlap in nonsmokers with chronic asthma
Researchers may be closer to finding the mechanism responsible for loss of lung elastic recoil and airflow limitation in nonsmokers with chronic asthma.
Asthma app helps control asthma: Alerts allergists when sufferers need assistance
New study in Annals of Allergy, Asthma and Immunology shows how an app directly connecting an allergist and an asthma sufferer can provide necessary intervention when asthma isn't under control.

Related Asthma Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Moving Forward
When the life you've built slips out of your grasp, you're often told it's best to move on. But is that true? Instead of forgetting the past, TED speakers describe how we can move forward with it. Guests include writers Nora McInerny and Suleika Jaouad, and human rights advocate Lindy Lou Isonhood.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...